within Pharmacolibrary.Drugs.ATC.D;

model D11AH05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.64,
    Cl             = 0.0026666666666666666,
    adminDuration  = 600,
    adminMass      = 0.6,
    adminCount     = 1,
    Vd             = 0.0048,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Dupilumab is a fully human monoclonal antibody that inhibits signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13) by binding to the IL-4 receptor alpha subunit. It is used in the treatment of moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis, and is an FDA and EMA approved biologic drug.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported from adult patients with atopic dermatitis; population PK analyses evaluated after subcutaneous administration in healthy or affected subjects.</p><h4>References</h4><ol><li><p>Li, Z, et al., &amp; Swanson, BN (2020). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects. <i>Clinical pharmacology in drug development</i> 9(6) 742–755. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.798&quot;>10.1002/cpdd.798</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32348036/&quot;>https://pubmed.ncbi.nlm.nih.gov/32348036</a></p></li><li><p>Cohen, YZ, et al., &amp; Xu, C (2022). Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe. <i>Clinical pharmacology in drug development</i> 11(5) 675–681. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1073&quot;>10.1002/cpdd.1073</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35278283/&quot;>https://pubmed.ncbi.nlm.nih.gov/35278283</a></p></li><li><p>Kamal, MA, et al., &amp; Arima, K (2022). Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitis. <i>Clinical and translational science</i> 15(10) 2342–2354. DOI:<a href=&quot;https://doi.org/10.1111/cts.13363&quot;>10.1111/cts.13363</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35986664/&quot;>https://pubmed.ncbi.nlm.nih.gov/35986664</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D11AH05;
